Programs Feature Simple Enrollment and Meaningful Financial Assistance March 8, 2011 Allergan, Inc. is seeking patients who are or will be receiving onabotulinumtoxinA injections for the treatment of cervical dystonia for potential observational study participation. Eligible patients may receive a patient stipend for their participation. The CD-PROBE Study is a Multi-center, Prospective, Naturalistic, Observational Registry of Cervical […]

March 9, 2011 Ipsen, manufacturer of Dysport for Injection (also known in the US as abobotulinumtoxinA neurotoxin), is contacting physicians to conduct an observational registry stud. The goal of the registry, ANCHOR-CD, is to collect and evaluate typical treatment response information from cervical dystonia patients currently being treated with market-available Dysport.  The registry will recruit up to 400 […]

Merz Pharmaceuticals Introduces Comprehensive Programs To Provide Patients With Financial Assistance For Xeomin® (incobotulinumtoxinA) Programs Feature Simple Enrollment And Meaningful Financial Assistance Greensboro, N.C., March 8, 2011/PRNewswire/ – Merz Pharmaceuticals today announced the launch of two programs to provide financial assistance to patients for their treatment with Xeomin (incobotulinumtoxinA). XEOMIN is a botulinum toxin type […]